ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TMDX vs ITGR // NET PROFIT MARGIN

TransMedics Group Inc. (NASDAQ) VS. Integer Holdings Corporation (NYSE) • 15-METRIC TALLY: TMDX 10 — ITGR 2
▲ NET PROFIT MARGIN LEADER: TMDX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TMDX VS. ITGR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TMDX ITGR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 59.90% 27.00% +32.90 TMDX /gross-margins <GO>
Return on Invested Capital (ROIC) 18.10% 6.00% +12.10 TMDX /roic <GO>
EV/EBITDA & P/E Valuation 14.6x 18.3x -3.70 TMDX /valuation <GO>
Free Cash Flow Yield 5.74% 2.44% +3.30 TMDX /fcf-yield <GO>
Operating Margin 17.90% 11.90% +6.00 TMDX /operating-margins <GO>
Net Profit Margin ACTIVE 31.40% 5.50% +25.90 TMDX /net-margins <GO>
Revenue Growth (YoY) 37.10% 8.00% +29.10 TMDX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.50 2.91 +0.59 TMDX /balance-sheet <GO>
Piotroski F-Score Quality 8/9 7/9 +1.00 TMDX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 32.5 59.3 -26.80 ITGR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.02 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 10.2x 38.9x -28.70 TMDX /forward-pe <GO>
Enterprise Scale & Market Cap $2.33B $4.30B -$1.97B ITGR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TMDX REV ITGR REV TMDX GROSS % ITGR GROSS % TMDX FCF ITGR FCF
FY 2025 $605.5M $1.85B 59.9% 27.0% $133.6M $105.1M
FY 2024 $441.5M $1.72B 59.4% 26.7% -$80.9M $99.8M
FY 2023 $241.6M $1.56B — — -$13.0M $110.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TMDX // BETA —
ITGR // BETA 1.02